The Valley Desk

NCT02277522 · Interventional trial

CD19 Redirected Autologous T Cells for Hodgkin Lymphoma

Overall registry status Terminated

Early Phase 1

Conditions Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov